American Bio Medica Corporation
ABMC
$0.0001
$0.000.00%
OTC PK
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 850.00K | -1.41M | -1.42M | -441.00K | -286.00K |
| Total Depreciation and Amortization | 46.00K | 51.00K | 53.00K | 58.00K | 63.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.16M | -29.00K | 584.00K | -246.00K | -207.00K |
| Change in Net Operating Assets | 143.00K | 620.00K | 784.00K | 490.00K | 103.00K |
| Cash from Operations | -1.12M | -768.00K | 3.00K | -139.00K | -327.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 247.00K | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 247.00K | -- | -- | -- | -- |
| Total Debt Issued | 1.64M | 1.86M | 1.67M | 1.95M | 2.32M |
| Total Debt Repaid | -722.00K | -1.17M | -1.80M | -1.94M | -2.14M |
| Issuance of Common Stock | -- | -- | 100.00K | 100.00K | 100.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 922.00K | 687.00K | -34.00K | 111.00K | 281.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.00K | -81.00K | -31.00K | -28.00K | -46.00K |